deferoxamine has been researched along with amg531 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Leitch, HA; Vickars, LM | 1 |
Bastian, TW; Chen, MJ; Connor, JR; Duck, KA; Georgieff, MK; Lanier, LM; Liu, ZJ; Michalopoulos, GC; Sola-Visner, MC | 1 |
Chen, YL; Cooper, N; Garbowski, M; Hider, R; Koonyosying, P; Porter, J; Psaila, B; Sola-Visner, M; Vlachodimitropoulou, E | 1 |
1 review(s) available for deferoxamine and amg531
Article | Year |
---|---|
Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?
Topics: Aged; Anemia; Benzoates; Blood Component Transfusion; Chelation Therapy; Combined Modality Therapy; Deferoxamine; Hematopoietic Cell Growth Factors; Humans; Hydrazines; Iron; Iron Chelating Agents; Iron Overload; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Off-Label Use; Phlebotomy; Practice Guidelines as Topic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Thrombocytopenia; Thrombopoietin | 2009 |
3 other study(ies) available for deferoxamine and amg531
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain barrier and impairs iron-dependent hippocampal neuron dendrite development.
Topics: Anemia, Iron-Deficiency; Animals; Benzoates; Biological Transport; Biomimetics; Blood-Brain Barrier; Cattle; Chelating Agents; Deferoxamine; Dendrites; Green Fluorescent Proteins; Hippocampus; Hydrazines; Iron; Mice; Microcirculation; Neuroglia; Neurons; Pyrazoles; Thrombocytopenia; Thrombopoietin | 2017 |
Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.
Topics: Animals; Benzoates; Cell Line, Tumor; Deferoxamine; Extracellular Space; Ferritins; Hepatocytes; Humans; Hydrazines; Insulin; Insulin Secretion; Insulin-Secreting Cells; Iron; Iron Chelating Agents; Myocytes, Cardiac; Pyrazoles; Pyridones; Rats; Reactive Oxygen Species | 2017 |